PubMed Health⌕ Search

PubMed · 11468573

[Mucosal endoscopic resections].

Abstract

Endoscopic mucosectomy is a newly developed endoscopic technique allowing the resection of large fragments of digestive mucosa. The main indications of this technique are the staging and/or the treatment of superficial lesions of esophagus, stomach and colon. Resections by endoscopic mucosectomy raise specific problems of macroscopic technique and histological analysis. For correct inclusion, fragments must be pinned under a rigid support by the endoscopist. Their lateral margins must be sampled independently. The fragment must be included in totality. The histological report must indicate the depth of the resection and its quality, particularly the status of lateral and deep margins. The main difficulties of the histological analysis are due to the frequent occurrence of coagulation artefacts, which may hamper a correct interpretation of the lesions, particularly along the lateral margins. The appropriate management of endoscopic mucosal resections requires a good collaboration between endoscopists and pathologists.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Tanière, P Peysson, J Y Scoazec. 2001. [Mucosal endoscopic resections].. https://pubmed.ncbi.nlm.nih.gov/11468573/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Colon polyps and cancer.

The superiority of colonoscopy to double-contrast barium enema in detecting neoplasia was finally demonstrated in 2000, but colonoscopic surveillance programs are still based on short-term observations and are mostly inadequate, despite the prospective design of the trials. The evaluation of the diagnostic accuracy of virtual colonoscopy is in progress, but its appropriate place in clinical gastroenterology has not yet been defined. There is now solid evidence that screening with fecal occult blood testing (FOBT) not only reduces the mortality from colorectal cancer, but also that the incidence is substantially reduced after removal of the precursor lesions. Feasibility studies for population screening are ongoing. A once-only sigmoidoscopy will probably not be an optimal method of screening, but may be added to a program with FOBT. Molecular stool screening is attractive, but still experimental. Colonoscopy is not attractive as an initial screening instrument, despite its high diagnostic accuracy, and should only be used for screening high-risk individuals. Genetic methods are playing an increasing role in defining prognostic markers for intestinal neoplasia, and it is recommended that information services should be established for the public. Chemopreventive studies have revealed that dietary fiber supplementation may not reduce the risk of adenomas; the opposite seems to be true for aspirin and non-aspirin NSAIDs, which are active in the early phase of carcinogenesis. New techniques for optimizing diagnostic and therapeutic colonoscopy have been introduced.

Colonic Neoplasms↗

Treatment of colon and rectal cancer.

During the past two decades, remarkable progress has been made in the treatment of cancers of the colon and rectum. Both oncologic and functional outcomes for this disease have improved dramatically. The reasons for the improved patient outcome in this disease include advances in knowledge of the biology of the disease, advances in surgical instrumentation and techniques, and ongoing advances in multimodality therapy, with the use of radiation and chemotherapy as an adjuvant to surgical resection. This review details many of these advances in a comprehensive manner and illustrates the necessity of a multidisciplinary approach for optimizing outcome for patients with these cancers.

Colonic Neoplasms↗